loading page

Management of Refractory Menstrual Bleeding in an Adolescent with Glanzmann Thrombasthenia: A case report
  • +2
  • Luke King,
  • Jessie Huff,
  • Deidre Heber,
  • Michal Ann Miller,
  • Brytanie Marshall
Luke King
Geisinger Health
Author Profile
Jessie Huff
Geisinger Health
Author Profile
Deidre Heber
Geisinger Health
Author Profile
Michal Ann Miller
Geisinger Medical Center
Author Profile
Brytanie Marshall
Geisinger Health
Author Profile

Abstract

Glanzmann Thrombasthenia (GT) is a rare bleeding disorder causing life-threatening bleeding at menarche in the adolescent female. We describe a 12-year-old menarchial female with persistent vaginal bleeding despite multiple treatment modalities including aminocaproic acid, recombinant factor VIIa (rFVIIa), intravenous estrogen, and gonadotropin receptor hormone agonists. Although the standard treatment of bleeding in patients with GT is primarily rFVIIa, new-onset menstrual bleeding in conjunction with an immature hypothalamus-pituitary-ovarian axis often requires expanding treatment to include multiple drug modalities. In our case, a two-step approach was necessary. First, targeting the cessation of menses. Secondly, optimizing long-term control of heavy menstrual bleeding.

Peer review status:Published

30 Sep 2020Published in Case Reports in Obstetrics and Gynecology volume 2020 on pages 1-3. 10.1155/2020/8848763